Corvus Pharmaceuticals, Inc. (CRVS) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Corvus Pharmaceuticals, Inc. (CRVS) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CRVS Income Statement

Corvus Pharmaceuticals, Inc. (CRVS) annual income statement — 12-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	29K	26K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-29K	-26K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	21.36M	19.3M	14.88M	12.19M	10.57M	10.26M	9.92M	8.11M	7.25M	5.93M	6.25M	5.65M	5.56M	5.62M	6.57M	5.67M	12.47M	7.01M	7.41M	6.81M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	3.58M	3.33M	3.7M	2.28M	2.12M	2.39M	2.47M	2.13M	2.03M	1.82M	2.18M	1.65M	1.59M	1.65M	1.98M	1.59M	2.11M	2.09M	2.31M	2.02M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	17.78M	15.96M	11.18M	9.94M	8.45M	7.87M	7.45M	5.97M	5.22M	4.11M	4.08M	4M	3.96M	3.97M	4.59M	4.08M	10.37M	4.92M	5.1M	4.79M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-21.36M	-19.3M	-14.88M	-12.22M	-10.57M	-10.26M	-9.92M	-8.11M	-7.25M	-5.93M	-6.25M	-5.65M	-5.56M	-5.62M	-6.57M	-5.67M	-12.47M	-7.01M	-7.41M	-6.81M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-102.06%	-88.08%	-49.94%	-50.73%	-45.72%	-72.87%	-58.68%	-43.43%	-30.49%	-5.57%	4.88%	0.26%	55.42%	19.83%	11.32%	16.8%	-37.87%	37.88%	35.44%	31.07%
EBITDA	-21.36M	-19.26M	-14.85M	-12.19M	-10.54M	-10.23M	-9.9M	-8.09M	-7.23M	-5.91M	-6.23M	-5.62M	-5.53M	-5.59M	-6.52M	-5.57M	-12.38M	-6.92M	-7.33M	-6.72M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-102.6%	-88.28%	-49.98%	-50.79%	-45.76%	-73%	-58.91%	-43.78%	-30.81%	-5.87%	4.4%	-0.92%	55.33%	19.29%	11.04%	17.05%	-38.48%	38.03%	35.43%	31.02%
D&A (Non-Cash Add-back)	0	34K	29K	26K	28K	29K	22K	20K	21K	21K	23K	28K	30K	36K	57K	94K	94K	92K	87K	93K
EBIT	0	-17.25M	-11.91M	-12.32M	-10.16M	-8M	15.19M	-12.11M	-40.22M	-4.26M	-5.7M	-5.65M	-5.56M	-5.62M	-6.57M	-5.67M	-12.47M	-7.01M	-7.41M	-9.23M
Net Interest Income	0	0	-1.78M	-1.9M	738K	639K	525K	508K	566K	434K	316K	380K	425K	403K	376K	318K	225K	100K	11K	-8K
Interest Income	0	0	0	-1.9M	738K	639K	525K	508K	566K	434K	316K	380K	425K	403K	376K	318K	225K	100K	11K	0
Interest Expense	1.91M	0	1.78M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8K
Other Income/Expense	1.02M	2.05M	1.19M	-104K	415K	2.26M	25.11M	-4.01M	-32.96M	1.67M	552K	-1M	-440K	-881K	-1.3M	-4.15M	-2.36M	-1.35M	-884K	-2.43M
Pretax Income	-20.34M	-17.25M	-13.69M	-12.32M	-10.16M	-8M	15.19M	-12.11M	-40.22M	-4.26M	-5.7M	-6.65M	-6M	-6.5M	-7.87M	-9.82M	-14.83M	-8.36M	-8.3M	-9.24M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	709K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	-4.11%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-20.34M	-17.96M	-13.69M	-12.32M	-10.16M	-8M	15.19M	-12.11M	-40.22M	-4.26M	-5.7M	-6.65M	-6M	-6.5M	-7.87M	-9.82M	-14.83M	-8.36M	-8.3M	-9.24M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-100.29%	-124.54%	-190.12%	-1.72%	74.74%	-87.66%	366.5%	-82.07%	-570.28%	34.46%	27.59%	32.22%	59.54%	22.24%	5.11%	-6.28%	-38.96%	28.84%	28.35%	-133.77%
Net Income (Continuing)	-20.34M	-17.96M	-13.69M	-12.32M	-10.16M	-8M	15.19M	-12.11M	-40.22M	-4.26M	-5.7M	-6.65M	-6M	-6.5M	-7.87M	-9.82M	-14.83M	-8.36M	-8.3M	-9.24M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.22	-0.19	-0.15	-0.18	-0.12	-0.10	-0.13	-0.18	-0.60	-0.07	-0.12	-0.14	-0.12	-0.14	-0.17	-0.21	-0.32	-0.18	-0.18	-0.20
EPS Growth %	-83.33%	-90%	-15.38%	0%	80%	-42.86%	-8.33%	-32.65%	-400%	50%	29.41%	35.38%	62.5%	22.22%	5.56%	-5%	-33.33%	35.71%	47.06%	-121.74%
EPS (Basic)	-0.22	-0.19	-0.15	-0.18	-0.12	-0.10	0.21	-0.18	-0.60	-0.07	-0.12	-0.14	-0.12	-0.14	-0.17	-0.21	-0.32	-0.18	-0.18	-0.20
Diluted Shares Outstanding	92.49M	92.37M	90M	79.74M	82.84M	77.77M	75.15M	68.35M	66.7M	59.71M	49.04M	49.04M	48.97M	47.5M	46.56M	46.55M	46.55M	46.55M	46.55M	46.55M
Basic Shares Outstanding	92.49M	92.37M	90M	78.96M	82.84M	77.77M	72.13M	68.35M	66.7M	59.71M	49.04M	49.04M	48.97M	47.5M	46.56M	46.55M	46.55M	46.55M	46.55M	46.55M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-